Learn about Conceptus
Visit our product sites
Essure®, the first and only non-incisional alternative to tubal ligation created by Conceptus, was approved in November 2002 for marketing in the United States by the FDA. Now women and their partners have a new option for permanent birth control.
Visit the
Essure Web site
.
Live Webcasts
Conceptus to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Conceptus Reports Sharply Higher Second Quarter Net Sales of $25.7 Million
Site Index
|
Contact Us
|
Privacy
|
Product Sites